|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 31/485 | (2006.01) |
| A61K 9/28 | (2006.01) | ||
| A61K 9/16 | (2006.01) | ||
| A61K 9/50 | (2006.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61P 25/04 | (2006.01) | ||
| A61P 25/36 | (2006.01) |
| (11) | Number of the document | 2092936 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09006024.5 |
| Date of filing the European patent application | 2001-02-08 | |
| (97) | Date of publication of the European application | 2009-08-26 |
| (45) | Date of publication and mention of the grant of the patent | 2013-03-20 |
| (46) | Date of publication of the claims translation | 2013-06-25 |
| (30) | Number | Date | Country code |
| 181369 P | 2000-02-08 | US |
| (72) |
Oshlack, Benjamin, US
Wright, Curtis, US
Haddox, J. David, US
|
| (73) |
EURO-CELTIQUE S.A.,
2, avenue Charles de Gaulle, 1653 Luxembourg,
LU
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Suardymui atsparios peroralinės opioidų agonistų kompozacijos |
| Tamper-resistant oral opioid agonist formulations |
| Payment date | Validity (years) | Amount | |
| 2020-01-21 | 20 | 347.00 EUR |